Pulse Explore Journal Club Debates Trending Researchers Journals

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Rituximab monotherapy for patients with recurrent primary CNS lymphoma | Synapse

March 8, 2011

View Full Paper

Rituximab monotherapy for patients with recurrent primary CNS lymphoma

Tracy T. BatchelorBroad Institute SGStuart A. GrossmanJohns Hopkins University

Tom MikkelsenNorthwestern University

Key Points

Key points are not available for this paper at this time.

Abstract

A Systematic Review of High-Dose Methotrexate for Adults with Primary Central Nervous System Lymphoma,

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Batchelor et al. (Tue,) studied this question.

synapsesocial.com/papers/6a6234e3f2fc5dc74fc21ba8 https://doi.org/https://doi.org/10.1212/wnl.0b013e31820f2d94

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Salvage therapy for primary CNS lymphoma with a combination of rituximab and temozolomide2004 · 217 citations
2Combined Immunochemotherapy With Reduced Whole-Brain Radiotherapy for Newly Diagnosed Primary CNS Lymphoma2007 · 406 citations
3Response criteria for phase II studies of supratentorial malignant glioma.1990 · 2,416 citations
4First report on a prospective trial with yttrium-90–labeled ibritumomab tiuxetan (Zevalin) in primary CNS lymphoma2008 · 45 citations
5Imaging of central nervous system lymphomas with iodine‐123 labeled rituximab2005 · 40 citations